acetazolamide has been researched along with Sarcoma 180 in 1 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Sarcoma 180: An experimental sarcoma of mice.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pashinskiĭ, VG | 1 |
1 other study available for acetazolamide and Sarcoma 180
Article | Year |
---|---|
[Experimental trial of antineoplastic preparations in combination with diuretics].
Topics: Acetazolamide; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Diuretics; Female; Furosemi | 1972 |